This article is more than 5 years old. Information may no longer be current.
FDA reminds physicians, pharmacists to stop certain acetaminophen prescriptions
The FDA has issued a reminder for health care professionals to stop prescribing and pharmacists to stop dispensing prescription drug combinations that contain more than 325 mg acetaminophen per tablet, capsule or other dosage unit.
The FDA recommended pharmacists receiving a prescription for a combination product for more than 325 mg acetaminophen per dosage unit should contact the prescriber to discuss a product with a lower dosage, according to an FDA Division of Drug Information press release.
“These products are no longer considered safe by FDA … and were voluntarily withdrawn by the manufacturers at the FDA’s request to protect consumers from the risk of severe liver damage, which can result from taking too much acetaminophen,” the release said. “We encourage pharmacists to return them to the wholesaler or manufacturer.”
The FDA has requested that wholesalers remove product codes for all prescription combination drug products with more than 325 mg acetaminophen per dosage unit from their ordering systems and return the products to manufacturers, according to the release.